Quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology

Background. In modern medicine, several diseases exist that require an interdisciplinary approach, and type 2 diabetes mellitus (DT2), which can be considered as an initially comorbid pathology, is certainly one of these. Reportedly, a high level of comorbidity not only changes the presentation of t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irina A. Kurnikova, Aigerim U. Ualihanova, Tatiana A. Meleshkevich, Lyudmila V. Kiryanova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2018
Materias:
Acceso en línea:https://doaj.org/article/c6fb6ee496304a55a06b97d4a99a43fd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c6fb6ee496304a55a06b97d4a99a43fd
record_format dspace
spelling oai:doaj.org-article:c6fb6ee496304a55a06b97d4a99a43fd2021-11-14T09:00:21ZQuality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology2072-03512072-037810.14341/DM9601https://doaj.org/article/c6fb6ee496304a55a06b97d4a99a43fd2018-05-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/9601https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Background. In modern medicine, several diseases exist that require an interdisciplinary approach, and type 2 diabetes mellitus (DT2), which can be considered as an initially comorbid pathology, is certainly one of these. Reportedly, a high level of comorbidity not only changes the presentation of the disease and makes diagnosis challenging, but in patients with comorbid diseases, the progression of the disease also increases, the prognosis worsens, and approaches to diagnosis and therapy change. For patients with DT2, a significant hallmark in the progression of the disease is the formation of insulin dependence. Determination of the mechanism behind comorbidity affecting the course and progression of diabetes, including the development of insulin dependence, necessitates research. In addition, the mutual influence of the quality of disease management of diabetes and the level of comorbidity also require investigation. Aims. We aimed to assess the influence of the quality of metabolic control and severity of comorbidity on the risk of insulin dependence in patients with DТ2. Materials and methods. A total of 166 patients with DT2 were divided into groups on the basis of the variant of hypoglycemic therapy, which was with either oral hypoglycemic agents or insulin therapy. The diagnostic complex included regular monitoring of glycaemia and the evaluation of the level of comorbidity. Results. The relationship between the quality of disease management and the level of comorbidity was established. With comorbidity measured using the Cumulative Illness Rating Scale (CIRS), a score above 14 points reduced the effectiveness of the therapy and triggered the initiation of more intensive glycemic control. Data on the influence of the quality of glycemic control and the parameters of comorbidity on the risk of insulin dependence in patients with DT2 were obtained. Conclusions. High CIRS scores in patients with DТ2 reduce the likelihood of achieving glycemic control targets. These patients require more intensive self-monitoring (at least four times during the day), and the risk of formation of insulin dependence is increased by 1.5 times.Irina A. KurnikovaAigerim U. UalihanovaTatiana A. MeleshkevichLyudmila V. KiryanovaEndocrinology Research Centrearticlediabetes mellitusself-monitoring of blood glucosecomorbidityinsulin requirementinsulin resistanceNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 21, Iss 2, Pp 118-127 (2018)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetes mellitus
self-monitoring of blood glucose
comorbidity
insulin requirement
insulin resistance
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetes mellitus
self-monitoring of blood glucose
comorbidity
insulin requirement
insulin resistance
Nutritional diseases. Deficiency diseases
RC620-627
Irina A. Kurnikova
Aigerim U. Ualihanova
Tatiana A. Meleshkevich
Lyudmila V. Kiryanova
Quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology
description Background. In modern medicine, several diseases exist that require an interdisciplinary approach, and type 2 diabetes mellitus (DT2), which can be considered as an initially comorbid pathology, is certainly one of these. Reportedly, a high level of comorbidity not only changes the presentation of the disease and makes diagnosis challenging, but in patients with comorbid diseases, the progression of the disease also increases, the prognosis worsens, and approaches to diagnosis and therapy change. For patients with DT2, a significant hallmark in the progression of the disease is the formation of insulin dependence. Determination of the mechanism behind comorbidity affecting the course and progression of diabetes, including the development of insulin dependence, necessitates research. In addition, the mutual influence of the quality of disease management of diabetes and the level of comorbidity also require investigation. Aims. We aimed to assess the influence of the quality of metabolic control and severity of comorbidity on the risk of insulin dependence in patients with DТ2. Materials and methods. A total of 166 patients with DT2 were divided into groups on the basis of the variant of hypoglycemic therapy, which was with either oral hypoglycemic agents or insulin therapy. The diagnostic complex included regular monitoring of glycaemia and the evaluation of the level of comorbidity. Results. The relationship between the quality of disease management and the level of comorbidity was established. With comorbidity measured using the Cumulative Illness Rating Scale (CIRS), a score above 14 points reduced the effectiveness of the therapy and triggered the initiation of more intensive glycemic control. Data on the influence of the quality of glycemic control and the parameters of comorbidity on the risk of insulin dependence in patients with DT2 were obtained. Conclusions. High CIRS scores in patients with DТ2 reduce the likelihood of achieving glycemic control targets. These patients require more intensive self-monitoring (at least four times during the day), and the risk of formation of insulin dependence is increased by 1.5 times.
format article
author Irina A. Kurnikova
Aigerim U. Ualihanova
Tatiana A. Meleshkevich
Lyudmila V. Kiryanova
author_facet Irina A. Kurnikova
Aigerim U. Ualihanova
Tatiana A. Meleshkevich
Lyudmila V. Kiryanova
author_sort Irina A. Kurnikova
title Quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology
title_short Quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology
title_full Quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology
title_fullStr Quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology
title_full_unstemmed Quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology
title_sort quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology
publisher Endocrinology Research Centre
publishDate 2018
url https://doaj.org/article/c6fb6ee496304a55a06b97d4a99a43fd
work_keys_str_mv AT irinaakurnikova qualityofglycemiccontrolinassessmentoftherequirementforinsulininpatientswithtype2diabetesandcomorbidpathology
AT aigerimuualihanova qualityofglycemiccontrolinassessmentoftherequirementforinsulininpatientswithtype2diabetesandcomorbidpathology
AT tatianaameleshkevich qualityofglycemiccontrolinassessmentoftherequirementforinsulininpatientswithtype2diabetesandcomorbidpathology
AT lyudmilavkiryanova qualityofglycemiccontrolinassessmentoftherequirementforinsulininpatientswithtype2diabetesandcomorbidpathology
_version_ 1718429555864109056